Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

194 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

NCT00913835

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • ImClone Investigational Site Joliet, Illinois, United States
  • ImClone Investigational Site Indianapolis, Indiana, United States
  • ImClone Investigational Site Baltimore, Maryland, United States
  • ImClone Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research

NCT02569983

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Ysbyty Gwynedd Bangor, United Kingdom
  • Birmingham City Hospital Birmingham, United Kingdom
  • Leeds General Infirmary Leeds, United Kingdom
  • Imperial Hospital NHS Trust London, United Kingdom
View all 14 locations
View Trial Details
Completed

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Scottsdale, Arizona, United States
  • Sedona, Arizona, United States
View all 138 locations
View Trial Details
Completed

Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.

NCT02785731

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Vivantes Auguste-Viktoria-Klinikum Berlin, Germany
  • Vivantes-Klinikum Neukölln Berlin, Germany
  • Charité - Universitätsmedizin Berlin Berlin, Germany
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

NCT02146313

Conditions
Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations
  • Florida Cancer Specialists - Sarasota (North Catttlemen Rd) Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
  • Hackensack Univ Med Ctr Hackensack, New Jersey, United States
View Trial Details
Completed

LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

NCT01015118

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +17 more
Locations
  • 1199.15.10113 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 1199.15.10030 Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • 1199.15.10001 Boehringer Ingelheim Investigational Site Santa Rosa, California, United States
  • 1199.15.10005 Boehringer Ingelheim Investigational Site Englewood, Colorado, United States
View all 281 locations
View Trial Details

Related conditions